Older Americans see notable rise in disability-free living from 2008 to 2017: Study
A sizable improvement was found in the prevalence of American adults aged 65 and older without disabilities—including memory, ...
The American Journal of Managed Care14h
Nipocalimab’s Promising Potential in Advancing gMG Care
For part 3 of our interview with Katie Abouzahr, MD, Johnson & Johnson Innovative Medicine, we discuss the favorable safety and efficacy profile of nipocalimab for generalized myasthenia gravis (gMG).